Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Ironwood Pharmaceuticals (IRWD) over the last 12 years, with Q3 2025 value amounting to $426000.0.

  • Ironwood Pharmaceuticals' Amortizatization of Intangibles rose 839.69% to $426000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 4238.75%. This contributed to the annual value of $8.1 million for FY2018, which is 3052.78% up from last year.
  • Ironwood Pharmaceuticals' Amortizatization of Intangibles amounted to $426000.0 in Q3 2025, which was up 839.69% from $418000.0 recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $426000.0 in Q3 2025 and a low of $378000.0 during Q1 2024